208 related articles for article (PubMed ID: 22903049)
1. Nanocarriers for dermal drug delivery: influence of preparation method, carrier type and rheological properties.
Schwarz JC; Weixelbaum A; Pagitsch E; Löw M; Resch GP; Valenta C
Int J Pharm; 2012 Nov; 437(1-2):83-8. PubMed ID: 22903049
[TBL] [Abstract][Full Text] [Related]
2. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance.
Mitri K; Shegokar R; Gohla S; Anselmi C; Müller RH
Int J Pharm; 2011 Jul; 414(1-2):267-75. PubMed ID: 21596122
[TBL] [Abstract][Full Text] [Related]
3. In vitro penetration properties of solid lipid nanoparticles in intact and barrier-impaired skin.
Jensen LB; Petersson K; Nielsen HM
Eur J Pharm Biopharm; 2011 Sep; 79(1):68-75. PubMed ID: 21664463
[TBL] [Abstract][Full Text] [Related]
4. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy.
Lombardi Borgia S; Regehly M; Sivaramakrishnan R; Mehnert W; Korting HC; Danker K; Röder B; Kramer KD; Schäfer-Korting M
J Control Release; 2005 Dec; 110(1):151-63. PubMed ID: 16297487
[TBL] [Abstract][Full Text] [Related]
5. Ultra-small NLC for improved dermal delivery of coenyzme Q10.
Schwarz JC; Baisaeng N; Hoppel M; Löw M; Keck CM; Valenta C
Int J Pharm; 2013 Apr; 447(1-2):213-7. PubMed ID: 23438979
[TBL] [Abstract][Full Text] [Related]
6. Solid lipid nanoparticles suspension versus commercial solutions for dermal delivery of minoxidil.
Padois K; Cantiéni C; Bertholle V; Bardel C; Pirot F; Falson F
Int J Pharm; 2011 Sep; 416(1):300-4. PubMed ID: 21704140
[TBL] [Abstract][Full Text] [Related]
7. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
Fang JY; Fang CL; Liu CH; Su YH
Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447
[TBL] [Abstract][Full Text] [Related]
8. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies.
Sanna V; Gavini E; Cossu M; Rassu G; Giunchedi P
J Pharm Pharmacol; 2007 Aug; 59(8):1057-64. PubMed ID: 17725847
[TBL] [Abstract][Full Text] [Related]
9. Optimisation of multiple W/O/W nanoemulsions for dermal delivery of aciclovir.
Schwarz JC; Klang V; Karall S; Mahrhauser D; Resch GP; Valenta C
Int J Pharm; 2012 Oct; 435(1):69-75. PubMed ID: 22154877
[TBL] [Abstract][Full Text] [Related]
10. Transdermal Lipid Nanocarriers: A Potential Delivery System for Lornoxicam.
Dasgupta S; Ray S; Dey S; Pal P; Mazumder B
Pharm Nanotechnol; 2017; 5(1):32-43. PubMed ID: 28948909
[TBL] [Abstract][Full Text] [Related]
11. Nanoemulsions (NEs), liposomes (LPs) and solid lipid nanoparticles (SLNs) for retinyl palmitate: effect on skin permeation.
Clares B; Calpena AC; Parra A; Abrego G; Alvarado H; Fangueiro JF; Souto EB
Int J Pharm; 2014 Oct; 473(1-2):591-8. PubMed ID: 25102113
[TBL] [Abstract][Full Text] [Related]
12. Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers.
Abdel-Mottaleb MM; Neumann D; Lamprecht A
Eur J Pharm Biopharm; 2011 Sep; 79(1):36-42. PubMed ID: 21558002
[TBL] [Abstract][Full Text] [Related]
13. Archaeosomes as carriers for topical delivery of betamethasone dipropionate: in vitro skin permeation study.
González-Paredes A; Manconi M; Caddeo C; Ramos-Cormenzana A; Monteoliva-Sánchez M; Fadda AM
J Liposome Res; 2010 Dec; 20(4):269-76. PubMed ID: 19954402
[TBL] [Abstract][Full Text] [Related]
14. SLN for topical application in skin diseases--characterization of drug-carrier and carrier-target interactions.
Küchler S; Herrmann W; Panek-Minkin G; Blaschke T; Zoschke C; Kramer KD; Bittl R; Schäfer-Korting M
Int J Pharm; 2010 May; 390(2):225-33. PubMed ID: 20153414
[TBL] [Abstract][Full Text] [Related]
15. Tacrolimus-loaded lecithin-based nanostructured lipid carrier and nanoemulsion with propylene glycol monocaprylate as a liquid lipid: Formulation characterization and assessment of dermal delivery compared to referent ointment.
Savić V; Ilić T; Nikolić I; Marković B; Čalija B; Cekić N; Savić S
Int J Pharm; 2019 Oct; 569():118624. PubMed ID: 31419461
[TBL] [Abstract][Full Text] [Related]
16. Lipid nanoparticles for improved topical application of drugs for skin diseases.
Schäfer-Korting M; Mehnert W; Korting HC
Adv Drug Deliv Rev; 2007 Jul; 59(6):427-43. PubMed ID: 17544165
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of stability and skin permeation by sucrose stearate and cyclodextrins in progesterone nanoemulsions.
Klang V; Matsko N; Zimmermann AM; Vojnikovic E; Valenta C
Int J Pharm; 2010 Jun; 393(1-2):152-60. PubMed ID: 20434531
[TBL] [Abstract][Full Text] [Related]
18. Topical delivery of lipophilic drugs from o/w Pickering emulsions.
Frelichowska J; Bolzinger MA; Pelletier J; Valour JP; Chevalier Y
Int J Pharm; 2009 Apr; 371(1-2):56-63. PubMed ID: 19135516
[TBL] [Abstract][Full Text] [Related]
19. Q10-loaded NLC versus nanoemulsions: stability, rheology and in vitro skin permeation.
Junyaprasert VB; Teeranachaideekul V; Souto EB; Boonme P; Müller RH
Int J Pharm; 2009 Jul; 377(1-2):207-14. PubMed ID: 19465098
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of silybin-loaded nanostructured lipid carriers.
Jia LJ; Zhang DR; Li ZY; Feng FF; Wang YC; Dai WT; Duan CX; Zhang Q
Drug Deliv; 2010 Jan; 17(1):11-8. PubMed ID: 19941406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]